Back
Redcare Pharmacy NV Quote, Financials, Valuation and Earnings
Sponsored
SAEYY
Sponsored
The dark truth about AI
Click here to learn more...
Buy
58
SAEYY
Redcare Pharmacy NV
Last Price:
16.05
Seasonality Move:
5.05%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Redcare Pharmacy NV Price Quote
$16.05
Redcare Pharmacy NV Key Stats
Buy
58
Redcare Pharmacy NV (SAEYY)
is a Buy
Day range:
$16.05 - $16.05
52-week range:
$9.80 - $17.94
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.36
P/B ratio:
5.85%
Volume:
1K
Avg. volume:
179
1-year change:
5.59%
Market cap:
$3.3B
Revenue:
$1.9B
EPS:
$-0.13
How Much Does Redcare Pharmacy NV Make?
-
How Much Are Redcare Pharmacy NV's Sales Annually?
SAEYY Revenues are $1.9B -
How Much Profit Does Redcare Pharmacy NV's Make A Year?
SAEYY net income is -$13M
Is Redcare Pharmacy NV Growing As A Company?
-
What Is Redcare Pharmacy NV's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.22% -
What Is Redcare Pharmacy NV's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Redcare Pharmacy NV Stock Price Performance
-
Did Redcare Pharmacy NV Stock Go Up Last Month?
Redcare Pharmacy NV share price went down by -7.81% last month -
Did SAEYY's Share Price Rise Over The Last Year?
SAEYY share price rose by 5.59% over the past 1 year
What Is Redcare Pharmacy NV 52-Week High & Low?
-
What Is Redcare Pharmacy NV’s 52-Week High Share Price?
Redcare Pharmacy NV has traded as high as $17.94 over the past 52 weeks -
What Is Redcare Pharmacy NV’s 52-Week Low Share Price?
Redcare Pharmacy NV has traded as low as $9.80 over the past 52 weeks
Redcare Pharmacy NV Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Redcare Pharmacy NV?
-
How Much Debt Does Redcare Pharmacy NV Have?
Total long term debt quarterly is $272.2M -
How Much Cash Does Redcare Pharmacy NV Have?
Cash and short term investments quarterly total is $234.4M -
What Is Redcare Pharmacy NV’s Book Value Per Share?
Book value per share is 2.82
Is Redcare Pharmacy NV Cash Flow Positive?
-
What Is SAEYY Cash Flow From Operations?
Cash flow from operations (TTM) is $33.8M -
What Is Redcare Pharmacy NV’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$20.6M -
What Is Redcare Pharmacy NV’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$71.2M
Redcare Pharmacy NV Return On Invested Capital
-
Is Management Doing A Good Job?
SAEYY return on invested capital is -3.09% -
What Is Redcare Pharmacy NV Return On Assets?
ROA measures how assets are converting to revenues and is -2.37% -
What Is SAEYY Return On Equity?
ROE is a measure of profitability and is -4.39%
Redcare Pharmacy NV Earnings Date & Stock Price
-
What Is Redcare Pharmacy NV's Stock Price Today?
A single share of SAEYY can be purchased today for 16.05 -
What Is Redcare Pharmacy NV’s Stock Symbol?
Redcare Pharmacy NV trades on the otcm under the ticker symbol: SAEYY -
When Is Redcare Pharmacy NV’s Next Earnings Date?
The next quarterly earnings date for Redcare Pharmacy NV is scheduled on December 15, 2024 -
When Is SAEYY's next ex-dividend date?
Redcare Pharmacy NV's next ex-dividend date is December 15, 2024 -
How To Buy Redcare Pharmacy NV Stock?
You can buy Redcare Pharmacy NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Redcare Pharmacy NV Competitors
-
Who Are Redcare Pharmacy NV's Competitors?
Below is a list of companies who compete with Redcare Pharmacy NV or are related in some way:
Redcare Pharmacy NV Dividend Yield
-
What Is SAEYY Dividend Yield?
Redcare Pharmacy NV’s dividend yield currently is 0% -
What Is Redcare Pharmacy NV’s Payout Ratio?
Redcare Pharmacy NV’s payout ratio is 0% -
When Did Redcare Pharmacy NV Last Pay A Dividend?
The latest dividend pay date is December 15, 2024 -
What Is Redcare Pharmacy NV’s Dividend Per Share?
Redcare Pharmacy NV pays a dividend of $0.00 per share
Redcare Pharmacy NV Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 22.05% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable